By Daniella Parra Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) announced a strategic partnership with Quality Chemical Laboratories, Inc. to manufacture Comera’s lead SQore excipients. Comera’s SQore platform transforms intravenously administered biologics into patient-delivered subcutaneous formulations, the company said in...

By Daniella Parra Avertix Medical announced that Professor Ian Meredith AM will join the Board of Directors, bringing extensive experience as a renowned interventional cardiologist and global medical executive, the company said. “Avertix has a meaningful product that holds the...

By Daniella Parra Promontory Therapeutics, a clinical stage pharmaceutical company focused on oncology, said it treated its first four patients in France for late-stage metastatic castration-resistant prostate cancer (mCRPC). The study is being led by oncologist Dr. Karim Fizazi at...

Join ICR for a retail industry outlook on Thursday, July 27, 2023 from 12 PM – 1 PM ET. With the constantly changing retail industry, key ways optimize a brand’s channel mix can be challenging. Industry experts will bring you...

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA), announced the successful completion of a private placement transaction, generating approximately $8.7 million. The notes, bearing a 6.0% annual interest rate and maturing in July 2028, can be converted into Eterna common...

By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) announced positive Phase 1 clinical trial results for their investigational immunotherapeutic, UB-312, in Parkinson’s disease patients. The data showed that the antibodies effectively engage with aggregated alpha-synuclein, a toxic protein associated with PD,...

By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) said it plans to conduct a clinical trial comparing its precision oral appliance therapy and hypoglossal nerve stimulation for severe obstructive sleep apnea treatment. This follows positive preliminary data from a study that...

By Daniella Parra Psychotropic industry innovator Lucy Scientific Discovery Inc. (Nasdaq: LSDI), has appointed Richard Nanula, former CFO at Amgen Inc. (Nasdaq: AMGN) and The Walt Disney Co. (NYSE: DIS), as its new CEO. With a career spanning senior executive...

By Daniella Parra Marti Technologies Inc. announced that its Class A Ordinary Shares and warrants have commenced trading on the NYSE American Stock Exchange under the symbols “MRT” and “MRTW,” respectively. One of the first Turkish companies to list in...

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) announced the appointment of Brant Binder, a seasoned leader and entrepreneur with more than 25 years of strategic expertise building and growing biotechnology companies and Richard Wagner, Ph.D., a biotechnology entrepreneur with more than...